Exelixis (EXEL) Tops Q4 EPS by 1c

Exelixis (NASDAQ: EXEL) reported Q4 EPS of ($0.30), $0.01 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $7.35 million versus the consensus estimate of $7.8 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c